ArticleObesity surgery2026
Reliability of the Overnight Dexamethasone Suppression Test in Patients Undergoing Bariatric Surgery.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBariatric surgery is the most effective treatment for severe cases in obesity. However, the altered gastrointestinal anatomy after bariatric surgery can affect drug absorption, potentially leading to false-positive results in diagnostic tests. This study aims to evaluate the reliability of dexamethasone suppression test (DST) in post-bariatric surgery patients and explore how different bariatric procedures influence DST outcomes.
methodsIn this single-center, cross-sectional study conducted at the Obesity Center in tertiary university hospital. Patients who had undergone bariatric surgery, completed at least 9-12 months of postoperative recovery, and had a pre-operative DST were included the study. Sociodemographic and clinical data were obtained. All patients underwent an overnight DST and laboratory tests.
resultsSixty-eight patients included study: 47 sleeve gastrectomy (SG), 21 Roux-en-Y gastric bypass (RYGB). Baseline weight and BMI were similar (p = 0.68, p = 0.873, respectively). At last follow-up, RYGB patients had lower weight compared to SG (p = 0.049). Postoperative DST levels showed no significant change in SG (p = 0.055), but increased significantly in RYGB (0.72 vs. 0.84; p = 0.028). Although postoperative DST values were higher in RYGB, the difference between groups was not significant (p = 0.196). A moderate positive correlation was found between pre- and postoperative DST values (r = 0.464, p < 0.001), with no association between DST and sex, surgery type, BMI, or weight loss.
conclusionsDespite potential alterations in absorption after bariatric surgery, the DST appeared to remain reliable and adequately suppressed cortisol in the majority of patients. Thus, our findings suggest that DST may be considered a safe and valid screening tool for Cushing's syndrome in patients undergoing bariatric surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.